The absence of significant increases in soluble endoglin levels in the setting of CKD in the current study, suggests that (despite the theoretical attractiveness of our initial hypothesis) that soluble endoglin is not an important factor in the etiology in the enhanced atherosclerosis and cardiovascular disease that accompanies CKD. This evidence concerns the gene ENG and atherosclerosis.